サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1549455

ゲノム編集の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Genome Editing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 231 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ゲノム編集の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年08月01日
発行: Value Market Research
ページ情報: 英文 231 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ゲノム編集市場の世界需要は、2023年の83億6,000万米ドルから2032年には354億9,000万米ドル近くの市場規模に達すると推定され、調査期間2024-2032年のCAGRは17.42%です。

ゲノム編集とは、生物の遺伝物質の正確な改変を可能にする一連の高度なバイオテクノロジー技術を指します。CRISPR-Cas9のような方法を利用することで、研究者は特定のDNA配列を標的として改変することができ、遺伝子変異の修正、望ましい形質の強化、遺伝子機能の調査を容易にします。この技術は、医療、農業、研究など様々な分野で変革の可能性を秘めており、健康状態の改善、農作物の収量増加、科学的理解の進展のための遺伝的介入を可能にします。

市場力学

CRISPRおよびその他の編集技術の進歩は、遺伝子操作のより正確で利用しやすい方法を提供し、市場の拡大を促進します。ゲノム編集は生物医学研究において極めて重要な役割を担っており、疾病メカニズムの解明、創薬、潜在的な治療法の発見に役立っており、バイオ医薬品分野での需要を牽引しています。遺伝性疾患の有病率の増加は、遺伝子変異を標的とする治療法の開拓を促進し、市場をさらに推進します。農業と家畜では、この編集は形質の強化、収量の向上、耐病性品種の開発に使用され、農業バイオテクノロジー分野での成長に寄与しています。支持的な規制の枠組み、研究開発投資の増加、さまざまな疾患の治療におけるゲノム編集の治療可能性が市場拡大を後押ししています。研究機関や業界関係者のコラボレーションが技術革新を促進し、新規の応用や治療につながります。オフターゲット効果や倫理的懸念などの課題にもかかわらず、ゲノム編集市場は、技術の進歩や、多様な分野にわたる生物医学研究、農業、治療介入に革命をもたらす可能性によって、拡大を続けています。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、ゲノム編集の世界市場における各セグメントを包括的に評価することもできます。ゲノム編集業界の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

ゲノム編集市場レポートのこのセクションでは、国別および地域別のセグメントに関する詳細なデータを提供し、それによって戦略家がそれぞれの製品またはサービスのターゲット層を特定する上で、今後のビジネスチャンスを支援します。

技術別

  • CRISPR-Cas9
  • TALENs/メガタール
  • ZFN
  • メガヌクレアーゼ
  • その他

送達方法別

  • 生体外
  • 生体内

用途別

  • 遺伝子工学（細胞株工学、動物遺伝子工学、植物遺伝子工学、その他）
  • 臨床応用（診断、治療開発）

モード別

  • 契約
  • インハウス

用途別

  • バイオテクノロジーおよび製薬会社
  • 学術・政府研究機関
  • 受託研究機関

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカにおけるゲノム編集市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 ゲノム編集-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 ゲノム編集の世界市場分析：技術別

  • 技術別の概要
  • 技術別の過去および予測データ分析
  • CRISPR-Cas9
  • TALENs/メガタール
  • ZFN
  • メガヌクレアーゼ
  • その他

第6章 世界のゲノム編集市場分析：送達方法別

  • 送達方法別概要
  • 送達方法別の過去および予測データ分析
  • 生体外
  • 生体内

第7章 ゲノム編集の世界市場分析：用途別

  • 概要：用途別
  • 過去および予測データ分析：用途別
  • 遺伝子工学（細胞株工学、動物遺伝子工学、植物遺伝子工学、その他）
  • 臨床応用（診断、治療開発）

第8章 ゲノム編集の世界市場分析：モード別

  • モード別概要
  • モード別過去および予測データ分析
  • 契約
  • インハウス

第9章 ゲノム編集の世界市場分析：最終用途別

  • 概要最終用途別
  • 最終用途別の実績データと予測データ分析
  • バイオテクノロジーおよび製薬企業
  • 学術・政府研究機関
  • 受託研究機関

第10章 世界のゲノム編集市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋セグメント別
    • アジア太平洋国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカセグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカセグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第11章 ゲノム編集企業の競合情勢

  • ゲノム編集市場の競合
  • パートナーシップ／共同研究／合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第12章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Merck KGaA
  • Cibus Inc.
  • Recombinetics
  • Sangamo Therapeutics
  • Editas Medicine
  • Precision BioSciences
  • Crispr Therapeutics
  • Intellia Therapeutics Inc.
  • Caribou Biosciences Inc
  • Cellectis S.A.
  • AstraZeneca
  • Takara Bio Inc.
  • Horizon Discovery Ltd.（Revvity Inc.）
  • Danaher Corporation
  • Transposagen Biopharmaceuticals Inc.
  • Genscript Biotech Corp
  • New England Biolabs
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Technology (USD MN)
  • CRISPR-Cas9 Market Sales By Geography (USD MN)
  • TALENs/MegaTALs Market Sales By Geography (USD MN)
  • ZFN Market Sales By Geography (USD MN)
  • Meganuclease Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Delivery Method (USD MN)
  • Ex-vivo Market Sales By Geography (USD MN)
  • In-vivo Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Genetic Engineering (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Others) Market Sales By Geography (USD MN)
  • Clinical Applications (Diagnostics, Therapy Development) Market Sales By Geography (USD MN)
  • Analysis By Mode (USD MN)
  • Contract Market Sales By Geography (USD MN)
  • In-House Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Biotechnology and Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic and Government Research Institutes Market Sales By Geography (USD MN)
  • Contract Research Organizations Market Sales By Geography (USD MN)
  • Global Genome Editing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Genome Editing Report
  • Market Research Process
  • Market Research Methodology
  • Global Genome Editing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Delivery Method
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Mode
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Technology (USD MN)
  • CRISPR-Cas9 Market Sales By Geography (USD MN)
  • TALENs/MegaTALs Market Sales By Geography (USD MN)
  • ZFN Market Sales By Geography (USD MN)
  • Meganuclease Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Delivery Method (USD MN)
  • Ex-vivo Market Sales By Geography (USD MN)
  • In-vivo Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Genetic Engineering (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Others) Market Sales By Geography (USD MN)
  • Clinical Applications (Diagnostics, Therapy Development) Market Sales By Geography (USD MN)
  • Global Market Analysis By Mode (USD MN)
  • Contract Market Sales By Geography (USD MN)
  • In-House Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Biotechnology and Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic and Government Research Institutes Market Sales By Geography (USD MN)
  • Contract Research Organizations Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112112859

The global demand for Genome Editing Market is presumed to reach the market size of nearly USD 35.49 Billion by 2032 from USD 8.36 Billion in 2023 with a CAGR of 17.42% under the study period 2024-2032.

Genome editing refers to a suite of advanced biotechnological techniques that enable precise modification of an organism's genetic material. By utilizing methods such as CRISPR-Cas9, researchers can target and alter specific DNA sequences, facilitating the correction of genetic mutations, enhancement of desirable traits, or investigation of gene function. This technology holds transformative potential across various fields, including medicine, agriculture, and research, allowing for tailored genetic interventions to improve health outcomes, increase crop yields, and advance scientific understanding.

MARKET DYNAMICS

Advancements in CRISPR and other editing technologies offer more precise and accessible methods for genetic manipulation, fostering market expansion. Genome editing plays a pivotal role in biomedical research, aiding in understanding disease mechanisms, drug discovery, and potential therapies, driving its demand in the biopharmaceutical sector. The increasing prevalence of genetic disorders fuels the development of therapies targeting genetic mutations, further propelling the market. In agriculture and livestock, this editing is used to enhance traits, improve yields, and develop disease-resistant varieties, contributing to its growth in agricultural biotechnology. Supportive regulatory frameworks, increased R&D investments, and the therapeutic potential of genome editing in treating various conditions fuel market expansion. Collaborations among institutions and industry players drive innovation, leading to novel applications and therapies. Despite challenges like off-target effects and ethical concerns, the genome editing market continues to expand, driven by technological advancements and its potential to revolutionize biomedical research, agriculture, and therapeutic interventions across diverse sectors.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Genome Editing. The growth and trends of Genome Editing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Genome Editing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

  • CRISPR-Cas9
  • TALENs/MegaTALs
  • ZFN
  • Meganuclease
  • Others

By Delivery Method

  • Ex-vivo
  • In-vivo

By Application

  • Genetic Engineering (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Others)
  • Clinical Applications (Diagnostics, Therapy Development)

By Mode

  • Contract
  • In-House

By End-use

  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Contract Research Organizations

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Genome Editing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Genome Editing market include Merck KGaA, Cibus Inc., Recombinetics, Sangamo Therapeutics, Editas Medicine, Precision BioSciences, Crispr Therapeutics, Intellia Therapeutics Inc., Caribou Biosciences Inc, Cellectis S.A., AstraZeneca, Takara Bio Inc., Horizon Discovery Ltd. (Revvity Inc.), Danaher Corporation, Transposagen Biopharmaceuticals Inc., Genscript Biotech Corp, New England Biolabs. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. GENOME EDITING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Delivery Method
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Mode
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL GENOME EDITING MARKET ANALYSIS BY TECHNOLOGY

  • 5.1. Overview By Technology
  • 5.2. Historical and Forecast Data Analysis By Technology
  • 5.3. CRISPR-Cas9 Historic and Forecast Sales By Regions
  • 5.4. TALENs/MegaTALs Historic and Forecast Sales By Regions
  • 5.5. ZFN Historic and Forecast Sales By Regions
  • 5.6. Meganuclease Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL GENOME EDITING MARKET ANALYSIS BY DELIVERY METHOD

  • 6.1. Overview By Delivery Method
  • 6.2. Historical and Forecast Data Analysis By Delivery Method
  • 6.3. Ex-vivo Historic and Forecast Sales By Regions
  • 6.4. In-vivo Historic and Forecast Sales By Regions

7. GLOBAL GENOME EDITING MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Genetic Engineering (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Others) Historic and Forecast Sales By Regions
  • 7.4. Clinical Applications (Diagnostics, Therapy Development) Historic and Forecast Sales By Regions

8. GLOBAL GENOME EDITING MARKET ANALYSIS BY MODE

  • 8.1. Overview By Mode
  • 8.2. Historical and Forecast Data Analysis By Mode
  • 8.3. Contract Historic and Forecast Sales By Regions
  • 8.4. In-House Historic and Forecast Sales By Regions

9. GLOBAL GENOME EDITING MARKET ANALYSIS BY END-USE

  • 9.1. Overview By End-use
  • 9.2. Historical and Forecast Data Analysis By End-use
  • 9.3. Biotechnology and Pharmaceutical Companies Historic and Forecast Sales By Regions
  • 9.4. Academic and Government Research Institutes Historic and Forecast Sales By Regions
  • 9.5. Contract Research Organizations Historic and Forecast Sales By Regions

10. GLOBAL GENOME EDITING MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE GENOME EDITING COMPANIES

  • 11.1. Genome Editing Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF GENOME EDITING INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Merck KGaA
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Cibus Inc.
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Recombinetics
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. Sangamo Therapeutics
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. Editas Medicine
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Precision BioSciences
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Crispr Therapeutics
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Intellia Therapeutics Inc.
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Caribou Biosciences Inc
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Cellectis S.A.
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. AstraZeneca
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments
  • 12.14. Takara Bio Inc.
    • 12.14.1 Company Overview
    • 12.14.2 Company Revenue
    • 12.14.3 Products
    • 12.14.4 Recent Developments
  • 12.15. Horizon Discovery Ltd. (Revvity Inc.)
    • 12.15.1 Company Overview
    • 12.15.2 Company Revenue
    • 12.15.3 Products
    • 12.15.4 Recent Developments
  • 12.16. Danaher Corporation
    • 12.16.1 Company Overview
    • 12.16.2 Company Revenue
    • 12.16.3 Products
    • 12.16.4 Recent Developments
  • 12.17. Transposagen Biopharmaceuticals Inc.
    • 12.17.1 Company Overview
    • 12.17.2 Company Revenue
    • 12.17.3 Products
    • 12.17.4 Recent Developments
  • 12.18. Genscript Biotech Corp
    • 12.18.1 Company Overview
    • 12.18.2 Company Revenue
    • 12.18.3 Products
    • 12.18.4 Recent Developments
  • 12.19. New England Biolabs
    • 12.19.1 Company Overview
    • 12.19.2 Company Revenue
    • 12.19.3 Products
    • 12.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies